Breast Cancer Update .com - Special Report: 21st Annual Miami Breast Cancer Conference 2004

You are here: Home: Special Report: 21st Annual Miami Breast Cancer Conference 2004:
J: Chemotherapy in Metastatic Breast Cancer: Select publications

Select Publications

Miles D et al. Combination versus sequential single-agent therapy in metastatic breast cancer. Oncologist 2002;7(Suppl 6):13-9. Erratum in: Oncologist 2003;8(1):127. Abstract

O'Shaughnessy J et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002;20(12):2812-23. Abstract

Seidman AD et al. Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer? Oncologist 2002;7(Suppl 6):20-8. Abstract

Talbot DC et al. Randomised, Phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines. Br J Cancer 2002;86(9):1367-72. Abstract

Table of Contents

Top of Page

Loews Miami Beach Hotel Miami Beach, Florida February 25 - 28, 2004
Editor’s Note: Bringing out the vote
Tumor Panel Cases Keypad Results

A:	Breast Cancer Prevention - Select publications

B:	HER2 Assessment - Select publications

C:	Adjuvant Endocrine Therapy in Postmenopausal Patients: ATAC - Select publications

D:	Adjuvant Endocrine Therapy in Postmenopausal Patients: Sequencing Tamoxifen and Aromatase Inhibitors - Select publications

E:	Adjuvant Chemotherapy in the Elderly - Select publications

F:	Clinical Trials of Adjuvant Trastuzumab - Select publications

G:	Sequencing Endocrine Therapy in Metastatic Disease - Select publications

H:	Ductal Carcinoma In Situ - Select publications

I:	Adjuvant Endocrine Therapy: Premenopausal Patients - Select publications

J:	Chemotherapy in Metastatic Breast Cancer - Select publications

Home · Contact us

Terms of use and general disclaimer